[at noodls] – Executive Brings Decades of Experience in Financial Management, Organizational Design and Development, and Strategic Business Planning WASHINGTON, DC, October 2, 2012 – CoStar Group, Inc. (NASDAQ: CSGP), … moreView todays social media effects on CSGPView the latest stocks trending across Twitter. Click to view dashboard […]
moreView todays social media effects on ATIView the latest stocks trending across Twitter. Click to view dashboard […]
moreView todays social media effects on RTNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – PARK CITY, Utah, Oct. 2, 2012 (GLOBE NEWSWIRE) — Skullcandy, Inc. (Nasdaq:SKUL) announced today that the Company will conduct a conference call to discuss its third quarter 2012 financial results on Thursday, … moreView todays social media effects on SKULView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NEWS RELEASE Investor Contact: Jessica Greiner Director of Investor Relations Trinity Industries, Inc. 214/631-4420 FOR IMMEDIATE RELEASE DALLAS – October 2, 2012 – Trinity Industries, Inc. (NYSE: TRN) … moreView todays social media effects on TRNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – McLean, VA – Booz Allen Hamilton maintains a strong history and commitment of working across all government and commercial healthcare segments, helping clients respond to complex challenges. Today, Booz … moreView todays social media effects on BAHView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – CONTACT: Tom Steinbauer Senior Vice President, Chief Financial Officer Ameristar Casinos, Inc This is an abstract of the original noodl. To continue reading this document, click here for the original version…. moreView todays social media effects on ASCAView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingCelgene (NASDAQ:CELG) moved closer today to securing another indication for its oncology drug, Abraxane, which is already approved as a second-line treatment for metastatic breast cancer. On … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]
[at Seeking Alpha] – Disliking The Guts Of This ETF: Sell URE moreView todays social media effects on UREView the latest stocks trending across Twitter. Click to view dashboard […]
moreView todays social media effects on MYMView the latest stocks trending across Twitter. Click to view dashboard […]
